GSK also run studies for patients with specific medical conditions. These trials are usually a kind of Phase 2a medical trial called proof of concept. Proof of concept studies are when we are ready to start the second phase of the trial process (phase 2 trials), but first want to look at a small group of patients with the disease which the drug is being developed to target. This gives us an idea that the drug is going to be effective and is safe and well tolerated in patients with that disease. These studies are conducted before major investment is made to go ahead with a large number of patients recruited into phase 2 trials.

We are currently recruiting for patients who have the following conditions:

PSORIASIS

ASTHMA

APDS - ACTIVATED PI3K DELTA SYNDROME / PALSI DISEASE

You can register your interest here